Name

PHRT

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for PHRT

Name

Alternate Names

Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1

Abbreviations

IBZ
MIH
PCB
PCH
PCI
PCZ

Category

Chemotherapy

Subcategory

Nonclassic alkylating agent

NSC Number

077213
77213

Primary Site

Brain tumors adjuvant and/or advanced disease
Cutaneous T-cell lymphoma
Hodgkin lymphoma
Non-Hodgkin lymphoma

Histology

None

Remarks

An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Ancef
Apo-Cefaclor
Apo-Cephalex
Ceclor
Ceclor CD
Cedax
Cefaclor
Cefadroxil
Cefadyl
Cefamandole
Cefazolin
Cefdinir
Cefditoren
Cefepime
Cefixime
Cefizox
Cefobid
Cefonicid
Cefoperazone
Cefotan
Cefotaxime
Cefotetan
Cefoxitin
Cefpodoxime
Cefprozil
Ceftazidime
Ceftibuten
Ceftin
Ceftizoxime
Ceftriaxone
Cefuroxime
Cefzil
Cephalexin
Cephalothin
Cephapirin
Cephradine
Ceporacin
Ceptaz
Claforan
Duricef
Fortaz
Keflex
Keflin
Keftab
Kefurox
Kefzol
Mandol
Maxipime
Mefoxin
Monocid
Novo-Lexin
Nu-Cephalex
Omnicef
PMS-Cephalexin
Rocephin
Suprax
Tazicef
Tazidime
Vantin
Velosef
Zinacef

Abbreviations

None

Category

Ancillary Agent

Subcategory

Antibacterial

NSC Number

None

Primary Site

None

Histology

None

Remarks

None

Coding

This drug should NOT be coded

Name

Alternate Names

Carbamo-hydroximic acid
Carbamohydroxamic acid
Carbamoyl oxime
Droxia
Hidrix
Hydrea
Hydreia
hydroxy-
Hydroxycarbamide
Hydroxycarbamine
Hydroxyl-urea
Hydura
Litaler
Litalir
Onco-Carbide
Oxyurea
SQ-1089
Urea
WR-83799

Abbreviations

HU
HUR
HYD

Category

Chemotherapy

Subcategory

Miscellaneous agent

NSC Number

032065
32065

Primary Site

Brain cancer
CML
Head and neck cancers
Melanoma
Ovarian cancer
Essential thrombocytosis
Polycythemia Vera

Histology

None

Remarks

FDA approved uses on chronic myelogenous leukemia, head and neck cancers, melanoma, and advanced ovarian cancer.

Coding

This drug should be coded
Glossary